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1. Introduction 
Morphological diagnosis by May-Gruenwald-Giemsa (MGG) staining is an essential method 
in clinical and laboratory hematology. In addition, the detection of chromosomal aberration 
by G-band methods, the phenotyping of surface markers by Flowcytometry (FCM) or 
genetic diagnosis by reverse transcriptase-polymerase chain reaction (RT-PCR), 
Fluorescence in situ hybridization (FISH) and Southern blotting are important approaches to 
facilitate the establishment of a definitive diagnosis. These methods are found to be much 
more useful for the diagnosis of specific diseases showing characteristic abnormalities on 
cytogenetics including acute myeloid leukemia (AML) with RUNX1-RUNX1T1 or PML-
RARA and chronic myelogenous leukemia (CML), BCR-ABL1 positivity and other such 
diseases etc (Arber et al, 2008, Vardiman et al, 2008). However, there are few methods other 
than morphological diagnosis that are described as effective for heterogenous populations 
comprising the majority of myelodysplastic syndrome (MDS), the detection of minimal 
residual diseases and the discrimination of cases showing slight dysplasia. Therefore, it is 
necessary to establish an effective technique of collecting other information.  
2. The diagnosis of blood pathological cell using flow cytometry 
The measurement of DNA content in the hematopoietic cells by flow cytometry (FCM) has 
been useful for the characterization of pathological blood cells, detection of residual diseases 
and prediction of disease prognosis in the hematological disorders. Trueworthy et al. 
(Trueworthy et al., 1992) reported that ploidy of lymphoblasts was the strongest predictor of 
treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood.  
Almeida et al. (Almeida et al., 1999) showed that the combined use of immunophenotyping 
and DNA ploidy studies by FCM is a suitable approach for minimal residural disease 
(MRD) investigation in multiple myeloma patients, based on their applicability and 
sensitivity.  Though FCM is an objective and reliable method to identify DNA ploidy of 
hematological cells, it is difficult to make inquiries about morphology and DNA ploidy in 
each cell (Sasaki et al., 1996).   
3. The structure and advantage of laser-scanning cytometry 
A laser-scanning cytometry (LSC) was developed by Kamentsky et al. (Kamentsky, LA & 
Kamentsky,LD, 1991) in 1991. The LSC (CompuCyte Corporation, Cambridge, MA) is an 
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instrument for being integrated image processing, flow cytometry, and automated digital 
microscopy, a rapidly high content analysis of cellular, tissue and other specimens. As cells 
pass through the scanning beams, the fluorescent light returns along the same path as the 
laser beams and is collected in the wavelength-specific photomultiplier. A photodiode 
scatter sensor detects scattered laser light for segmenting or brightfield imaging with 
Nomarski-like three-dimensional details.  Specimens are observed with the microscope that 
is a component of the whole instrument and the morphological data are captured through 
the microscopic light path, and the LSC excites fluorescent-stained samples with up to 3 
different wavelength, and acquires stoichiometric fluorescent and morphological data in as 
many as 5 detectors per laser.  
LSC enables us to measure the cell population fixed on the slide glass by rapid scanning and 
acquire the fluorescent information of each cell like as FCM, and still better, LSC makes it 
possible to recall the cells of interest and evaluate their morphology with the microscope by 
switching the status between routine morphology observation and fluorescence condition 
(Martin-reay et al. 1994). LSC has recently been used for immunophenotyping of 
hematological malignancies in smear specimens or needle aspiration biopsy. Clatch et al. 
analyzed a total of 71 specimens including peripheral blood, tissue biopsy, bone marrow 
aspirates and lymphoid tissue, and concluded that LSC analysis provides advantages over 
FCM in point of using cells on the slide, examining microscopically at any time, low cost, 
easy for preparation (Clatch, 2001, Clatch & Walloch, 1997, Clatch & Foreman, 1998).  
Whereas FCM yields useful information on the expression pattern and the amount of 
cellular molecules, LSC provides the morphologic information on the precise location of the 
molecules in the cell and makes it possible to retrieve the data file to examine the fluorescent 
features and morphology from a small number of the cells fixed onto the slide glass (Sasaki 
et al., 1996, Martin-Reay et al., 1994). 
4. Comparative cell cycle analysis with LSC and FCM 
A human myelocytic leukemia cell line, HL60 cells were fixed in 5ml cold ethanol (70%) for 
30 minutes at 4°C, and after washing with PBS, the cells were resuspended in 500μl PBS and 
incubated with 2 mg/ml ribonuclease A (Sigma) at 37°C for 30 minutes, followed by the 
addition of 50μg/ml propidium iodide (PI, Sigma, ST. Louis, Missouri, USA) at room 
temperature for 20 minutes for DNA staining. HL60 cells were measured with FACS Calibur 
flow cytometer (Becton Dickinson Immunocytometry Systems, Franklin Lakes, NJ, USA). PI 
fluorescence was measured at FL2 channel. Up to 10,000 events for each sample was 
measured by Cellquest software (BD Bioscience, Mansfield, MA, USA) and the cell cycle was 
analyzed with ModFit LTTM (Verity Software House, Inc, Topsham, ME, USA).  
LSC is the apparatus for analyzing the fluorescence of the cells fixed onto the slide glass and 
is capable of evaluating the cell cycle by integrating the data of the cells whose nuclei are 
stained with PI. As the cell cycle analysis has been established and standardized by FCM, 
we examined the consistency of the data by LSC with that of FCM using HL60 cells in the 
proliferating phase. Figure 1 shows the comparative cell cycle analysis with FCM and LSC. 
The percentages of G0/G1, S, G2/M and subG1 phases of HL60 cell population measured 
with FCM were 35.7%, 58.2%, 6.0% and 0.5%, respectively (Fig. 1a.), whereas those analyzed 
with LSC were 55.7%, 25.8%, 20.2% and 1.0%, respectively (Fig. 1b.) (Tsujioka et al.,2008). 
Collectively, cell cycle analysis by the use of LSC did not always coincide with that of FCM 
because of different analytic methods, but both histogram patterns seemed similar to each 
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other. The measurement of DNA content of blood cells by FCM has been widely established 
and its accuracy control is excellently maintained. In contrast, the accuracy control of LSC 
method might be inferior to that of FCM. As shown in Figure 1, the peak pattern of the 
histogram demonstrating G0/G1 and G2/M phases is rather broad in LSC than that of FCM. 
It was reported that the coefficient of variation (CV) is almost in the range of 5-6% by LSC as 
compared with 3-7% in the case of FCM, but structural changes in the cells and nuclei 
associated with cell deposition on the solid surface of the slide glass may result in a 
broadening of the CV (Martin-Reay et al., 1994, Tarnok & Gerstner AOH, 2002, Kamada et 
al., 1997). In LSC, adjacent cells are often falsely recognized as a single giant cell with 
multiple nuclei, and the background fluorescence is not negligible particularly in the case of 
bone marrow specimens. To avoid such disadvantages, a relatively small number of the cells 
(less than five thousand cells per acquisition area) should be treated for cytospin 
preparation and the fluorescence-stained slide glass should be sufficiently washed 
(Pozarowski et al., 2006). Despite of some adverse points mentioned above, LSC exerts an 
excellent function that it enables us to evaluate both the morphology and the fluorescence 
information on each cell, and still better, it enables us to retrieve the individual cell and its 
information at any time as long as the fluorescence is sustained (Rodenburg et al., 1987, 
Chen TL et al., 1995, Rew et al., 1998, Kamiya et al., 1998).  
 
 
Fig. 1. Comparative cell cycle analysis with FCM and LSC (Tsujioka et al.,2008) 
a) HL-60 cells were stained by PI as described in Materials and methods, then the cell cycle 
analysis was performed using FCM. 1:subG1 phase, 2: G0/G1 phase, 3: S phase, 4: G2/M 
phase 
b) HL-60 cells were stained by PI as described in Materials and methods, then the cell cycle 
analysis was performed using LSC. 1: subG1 phase, 2: G0/G1 phase, 3: S phase, 4: G2/M 
phase 
5. The model study on diagnosis of cases with megaloblastic anemia using 
LSC 
Megaloblastic anemia is a common hematological disorder which is characterized by 
ineffective hematopoiesis due to impaired DNA synthesis of the bone marrow cells. This 
disease is usually caused by the disturbance of vitamin B12 absorption in pernicious anemia or 
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after gastrectomy, folic acid deficiency, or the adverse effect of some cytotoxic drugs. The 
prominent morphological features of megaloblastic anemia are megaloblasts in the erythroid 
lineage and neutrophils with hypersegmented nucleus or with larger cell size such as giant 
metamyelocytes and giant band cells in the myeloid lineage (Shojania, 1980, Parry, 1980, Beck, 
1991). In the present study, we assumed that the dysplastic bone marrow cells found in 
megaloblastic anemia are the adequate candidates for DNA ploidy analysis. We performed the 
measurement of DNA ploidy with morphological analysis of a single cell by LSC.  
6. DNA ploidy analysis on megaloblastic anemia using LSC 
Bone marrow smears were obtained by bone marrow aspirations of 6 patients with 
megaloblastic anemia including 5 cases with pernicious anemia and 1 case with after 
gastrectomy. Normal bone marrow as a control was obtained from 3 volunteers with non-
hematological diseases for routine hematological examination after informed consent. 
Normal peripheral blood cells were obtained from 9 healthy volunteers. Alternatively, we 
used MDS92 cell line which was established from the bone marrow of an MDS patient 
(Tohyama et al., 1994). 
After the sample smears were stained with May-Gruenwald-Giemsa, the cells were 
morphologically assessed, captured visually with a CCD camera and their coordinates (x- 
and y-) on the slide were recorded (Fig.2a-g, upper stand.) (Tsujioka et al., 2008). Next the 
sample smears were destained with ethanol/acetate, treated with 2mg/ml of ribonuclease A 
for 1 hour at 37°C, and 100μg/ml of PI was added to the specimen slides (Fig. 2a-g, lower  
 
a b
c d
e f
g
 
Fig. 2. Morphologic features of the cells with megaloblastic anemia and MDS92 cells (MDS 
cell line). Upper stand: May-Gruenwald-Giemsa staining, Lower stand: PI staining 
a) normal neutrophil, b) hypersegmented neutrophil, c) giant metamyelocyte,  
d) polychromatic megaloblast, e) neutrophil in MDS92 cell line, f) hyposegmented mature 
neutrophil in MDS92 cell line, g) giant metamyelocyte in MDS92 cell line (Original 
magnification 400X) 
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stand.) (Tsujioka et al.,2008). The slides were washed, scanned with the objective mode of 
LSC and the fluorescence data of more than 5,000 cells per slide were acquired. The nuclear 
stain PI was excited by a 488 nm wave-length argon-ion laser, and the red fluorescence 
emission was measured by appropriately filtered photomultiplier tubes. The mode value of 
DNA content was adjusted to 2.0 (this value implies a diploid cell at the G0/G1 phase). The 
data of each cell were retrieved corresponding to the identical cells formerly stained by 
May-Gruenwald-Giemsa according to their coordinates.  
7. DNA ploidy analysis in abnormal neutrophils of the patients with 
megaloblastic anemia  
Hypersegmented neutrophils, giant metamyelocytes, giant band cells or giant neutrophils 
are often detected in the peripheral blood or in the bone marrow of the patients with 
megaloblastic anemia. It has been one of the simple questions whether or not these 
morphologically abnormal neutrophils are ordinary diploid cells or perhaps hyperploid 
cells. Hence we selected these cells in May-Gruenwald-Giemsa-stained smears and 
subsequently determined their DNA ploidy after PI staining. We compared the DNA 
content of abnormal neutrophils found in the bone marrow of the patients with 
megaloblastic anemia with normal counterparts in the bone marrow of non-hematological 
disease. The average values±SD of DNA ploidy in normal neutrophils in the peripheral 
blood of healthy volunteers and hypersegmented neutrophils found in megaloblastic 
anemia were 2.0±0.1 (n=181) and 2.0±0.2 (n=18), respectively (data not shown). The average 
values±SD of DNA ploidy in normal neutrophils and hypersegmented neutrophils in the 
bone marrow were 2.0±0.1 (n=38) and 1.9±0.1 (n=36), respectively(data not shown). These 
data represented no significant difference of DNA content of normal neutrophils and 
hypersegmented neutrophils in both the peripheral blood and the bone marrow. Therefore it 
was suggested that DNA ploidy of hypersegmented neutrophils is not significantly 
increased as compared with that of normal neutrophils.  
Giant metamyelocytes, giant band cells and giant neutrophils are extraordinary huge ones 
often detected in the bone marrow of the patients with megaloblastic anemia. The average 
DNA ploidy in giant metamyelocytes and giant neutrophils were 2.9±0.1 (n=23, p<0.01) and 
3.5±0.2 (n=20, p<0.01), respectively. These data demonstrated that giant neutrophilic series 
have significantly higher DNA ploidy as compared with that of normal bone marrow 
counterparts (data not shown) (Tsujioka et al.,2008). 
8. DNA ploidy analysis in the erythroid cells representing the megaloblastic 
change 
The erythroid cells in the megaloblastic anemia represent morphological features of the 
comparatively large size and the delay of chromatin condensation as compared with 
cytoplasmic maturation. We measured DNA content of the abnormal erythroblasts 
including basophilic and polychromatic megaloblasts of the patients with megaloblastic 
anemia and compared them with normal erythroblasts of the bone marrow of non-
hematological diseases 
Table 1 show the distribution of DNA content in normal erythroblasts and megaloblasts, 
respectively. The cell cycle was divided into three phases by the measured values of DNA 
content: G0/G1 phase (1.8-2.4), S phase (2.5-3.8) and G2/M phase (3.9-4.2), and the 
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distribution pattern of three phases was compared between normal erythroblasts and 
megaloblasts (Tsujioka et al.,2008). Table 1 shows that the cell fraction in S phase was 
increased in the case of megaloblasts (Tsujioka et al.,2008). Wickramasinghe et al. 
(Wickramasinghe et al., 1982) previously reported the cell cycle distribution of normal 
erythroblasts in the bone marrow using a technique of combined Feulgen 
microspectrophotometry and 3H-thymidine autoradiography and showed that the 
distribution of cell cycle was 32% in G0/G1 phase, 62% in S phase, 6% in G2/M phase in 
basophilic erythroblasts, and 15% in G0/G1 phase, 77% in S phase, 7% in G2/M phase in 
polychromatic erythroblasts. Fibach E et al. (Fibach & Rachmilewitz EA, 1993) reported that 
peripheral blood mononuclear cells were cultured with erythropoietin (2.0U/ml) and the 
cell cycle distribution of the erythroblasts was 47% in G0/G1 phase, 40 % in S phase and 13 
% in G2/M phase. Considering Fibach’s study and our data, the report by Wickramasinghe 
et al. might include overestimated proportion of S phase in normal erythroblasts.  
On the contrary, the average DNA content of the cells in S phase were 2.7±0.1 in normal 
erythroblasts (n=27, range: 2.2-3.8) and 2.9±0.1 in megaloblasts (n=37, range: 2.3~3.8), and 
these values showed no significant difference (Tsujioka et al., 2008).  
 
   
  
Percentage 
 
 G0/G1 S G2M 
Megaloblastic 32.3% 59.7% 8.1% 
anemia (n=20) (n=37) (n=5) 
(6cases)    
Normal control 66.1% 24.8% 9.2% 
(3 cases) (n=72) (n=27) (n=10) 
Table 1. Proportion of the cells in three phases of cell cycle in normal erythroblasts and 
megaloblasts 
The data of normal erythroblasts (n=109) were obtained from the bone marrow of 3 
volunteers and those of megaloblasts (n=62) from the bone marrow of 6 patients with 
megaloblastic anemia. The specimens were stained by PI and up to 5,000 events for each 
sample were collected and analyzed by LSC. Normal samples and those with megaloblastic 
anemia were divided to G0/G1 (1.8-2.4), S (2.5-3.8), G2/M (3.9-4.2) phase. The G0/G1, S, 
G2/M fractions of the normal control were 66.1% (n=72), 24.8% (n=27), 9.2% (n=10), 
respectively. The G0/G1, S, G2/M fractions of those with megaloblastic anemia were 32.3% 
(n=20), 59.7% (n=37), 8.1% (n=5), respectively.    
9. DNA ploidy analysis in normal megakaryocytes 
In this study, we could not exactly estimate the analysis of DNA ploidy in megakaryocytes 
(MGK) with dysplasia, because bone marrow with megaloblastic anemia frequently shows 
hypercellular marrow and there are many other cells around MGK. Figure 3 shows DNA 
ploidy of MGK in normal bone marrow. DNA ploidy of MGK is much greater than that of 
erythroid cells or myeloid cells. As hematological diseases often show the characteristics of 
www.intechopen.com
Application of Laser Scanning Cytometry to Clinical and Laboratory Hematology   
 
191 
MGK, such as micro-MGK and mononuclear-MGK in MDS or small-MGK in chronic 
myelogenous leukemia (Brunning et al, 2008, Vardiman et al, 2008), it would be interesting 
to measure the DNA ploidy of these cells using LSC in the future.      
 
 
Fig. 3. DNA ploidy of megakaryocyte in normal bone marrow 
a-d: May-Gruenwald-Giemsa staining 
e-h: PI staining 
a-h: megakaryocyte (Original magnification 400X) 
The numerical value in the figure indicates DNA ploidy. 
10. Overview of DNA ploidy analysis on megaloblastic anemia using laser 
scanning cytometry 
In the present study, we have investigated the DNA ploidy of the erythroid /myeloid cells 
of the patients with megaloblastic anemia, because this anemia is characterized by 
dysplastic and often extraordinarily large erythroid/myeloid cells whose DNA ploidy is 
worthy to be examined. We actually confirmed for the first time that the DNA ploidy of 
giant metamyelocytes, giant band cells and giant neutrophils often found in the specimens 
of megaloblastic anemia is significantly increased over the diploid pattern of normal 
myeloid counterparts. As such maturing myeloid cells are considered to lose a capacity of 
cell division, the DNA ploidy of giant myeloid cells is obviously abnormal. On the contrary, 
the DNA ploidy of hypersegmented neutrophils is not significantly increased over normal 
diploid pattern.  
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As the studies dealing with clinical samples, DNA staining of the cells from normal or 
pathological tissues will be the best application for LSC. Our data about the DNA ploidy of 
the erythroid /myeloid cells of the patients with megaloblastic anemia demonstrate the 
impaired nuclear division although the underlying molecular mechanisms leading to the 
dysplasia remain unknown. From our data, we suspect that a larger number of megaloblasts 
are in the way of S-phase as a result of impaired DNA synthesis although it is not 
determined whether cell cycle process is retarded or arrested. 
11. The future of LSC in clinical and laboratory hematology 
The advantage of the 4th edition of the WHO classification in 2008 is the classification by 
genetic criteria newly defined for some diseases (eg: JAK2/V617F, MPLW515, c-Kit D816V) 
particularly among the myeloproliferative neoplasms (Vardiman et al, 2008). 
Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases 
characterized by cytopenia, dysplasia, ineffective hematopoiesis and increased risk of 
developing acute myeloid leukemia. These are highly heterogenous populations except in 
MDS associated with isolated del (5q) defined by genetic criterion only (Hasserjian et al, 
2008). Therefore, morphological diagnosis of MDS by MGG staining has been the main 
method of diagnosis lagging behind the progress of genetic analysis made in other fields. 
However it is very difficult for us to distinguish between hypoplastic MDS without 
chromosomal abnormality and aplastic anemia with slight dysplasia by morphological 
diagnosis alone. DNA ploidy analysis using LSC is useful as an adjunct to the diagnosis of 
these confusing cells. In this study, though we performed the measurement of DNA ploidy 
in dysplastic cells with megaloblastic anemia as a previous step, we further intend to 
measure the DNA ploidy of several other hematopoietic cells in the near future in order to 
clarify the relation of DNA ploidy to cell dysplasia in bone marrow disorders such as 
neutrophils with nuclear hypolobation and micro-megakaryocyte in MDS using LSC.  
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